EQS-News: MEDIQON Group AG
/ Key word(s): Half Year Report
MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022
Today, MEDIQON Group AG published its Interim Report 2022.
“The overall positive development of all key figures reflects the stable earning power of the operating group companies. We are delighted that the growth of the group continued again in the first half of the year, and we would like to thank all the teams at our subsidiaries for the good results!” CEO Jan-Hendrik Mohr adds: “The operating companies performed well in the turbulent macroeconomic environment in the first half of 2022. The current capital market volatility is reflected in our securities portfolio quite pronounced at the moment. We have used the upheavals to selectively build up stock positions and see considerable opportunities for MEDIQON Group AG in the coming weeks and months.” In addition to the financial statement for MEDIQON Group AG as the parent, the company also published the first-time and voluntarily prepared consolidated interim accounts. The financial statements are unaudited. The Interim Report 2022 can be downloaded via the website of the company: Annual and Interim Reports - MEDIQON group AG (mediqon-group.de).
30.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG. |
Language: | English |
Company: | MEDIQON Group AG |
Herzog-Adolph-Strasse 2 | |
61462 Königstein im Taunus | |
Germany | |
Phone: | +49 (0) 6174-9687040 |
Fax: | +49 (0) 6174-9687043 |
E-mail: | ir@mediqon-group.de |
Internet: | www.mediqon-group.de |
ISIN: | DE0006618309, DE000A254TL0 |
WKN: | 661830, A254TL |
Listed: | Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart |
EQS News ID: | 1453953 |
End of News | EQS News Service |
|
1453953 30.09.2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.